FDA Inspection 1191063 — St Louis Children's Hospital

St Louis Children's Hospital — FEI 1937473

The FDA completed an inspection of St Louis Children's Hospital on November 10, 2022 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 10, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Saint Louis, MO (United States)